Complex renal cysts associated with crizotinib treatment-Reference-Cited by-同舟云学术

Complex renal cysts associated with crizotinib treatment

Published:2015-03-10 Issue:6 Volume:4 Page:887-896
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Schnell Patrick¹,Bartlett Cynthia H.¹,Solomon Benjamin J.²,Tassell Vanessa³,Shaw Alice T.⁴,de Pas Tommaso⁵,Lee Soo-Hyun⁶,Lee Geon Kook⁶,Tanaka Kaoru⁷,Tan Weiwei³,Tang Yiyun³,Wilner Keith D.³,Safferman Allan¹,Han Ji-Youn⁶

Affiliation:

1. Pfizer Oncology; New York New York

2. Peter MacCallum Cancer Centre; Melbourne Australia

3. Pfizer Oncology; La Jolla California

4. Massachusetts General Hospital; Boston Massachusetts

5. European Institute of Oncology; Milan Italy

6. National Cancer Center; Goyang Gyeonggi Korea

7. Kinki University Faculty of Medicine; Osaka Japan

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cam4.437/fullpdf

Reference29 articles.

1. Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma;Christensen;Mol. Cancer Ther.,2007

2. An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms;Zou;Cancer Res.,2007

3. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer;Rikova;Cell,2007

4. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer;Soda;Nature,2007

5. The therapeutic potential of anaplastic lymphoma kinase inhibitors in lung cancer: rationale and clinical evidence;Weickhardt;Clin. Invest.,2011

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nephrotoxicity of targeted therapy used to treat lung cancer;Frontiers in Immunology;2024-07-04

2. Cancer drugs and acute kidney injury: new therapies and new challenges;Current Opinion in Nephrology & Hypertension;2024-05-07

3. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literature;Diagnostic Pathology;2024-04-14

4. From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC);Diagnostics;2023-12-25

5. An update on breast cancer chemotherapy-associated toxicity and their management approaches;Health Sciences Review;2023-12